FAQs
CureGBM is dedicated to pioneering a breakthrough in brain tumour treatment through innovative sonodynamic therapy. Our non-invasive approach gently targets tumours, improving patient outcomes and enhancing their quality of life. Join us in our mission to transform healthcare.
Is there a Trial open?
The trial is not yet open. We are aiming for February 2026 as our launch date. Please contact us for information & updates.
Have you gained the necessary permissions to start a trial?
In Q4 2025, we will submit our application to the Swissmedic ethical committee, for permission to start the trial.
Where will the trial be held and who will lead it?
All trial treatments will be performed in University Hospital Bern, led by Prof. Philippe Schucht who specialises in brain tumours and has 20yrs international clinical trial experience.
How much will the trial cost?
Trial treatment is free, thanks to the financial support from our funders. We are in negotiation with other partners to support your travel and accommodation costs (tbc).
What if I want more than 4 treatments?
Further treatments will require submission to the Swissmedic ethical board for consideration of compassionate treatments, which is not guaranteed. Further treatments are not funded. Unfortunately patients will have to make their own financial arrangements for additional treatments. Currently we estimate that a further four treatments would cost £45,000, excluding travel and accommodation (tbc).
Patients, families, carers, and clinicians
We will update this website as we progress through local and National Swiss Ethical and Regulatory bodies.
Investors
Please contact us at Investor@CureGBM.co.uk and we will respond with the password to access the Investor pages on this website.
